1.53

2.68% 0.04

Lixte Biotechnology Holdings Inc (LIXT)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$1.49

Offen:

$1.48

24-Stunden-Volumen:

21,024

Relative Volume:

0.04

Marktkapitalisierung:

$3.35M

Einnahmen:

Nettoeinkommen (Verlust:

$-4.69M

KGV:

-0.4135

EPS:

-3.7

Netto-Cashflow:

$-3.81M

1W Leistung:

-4.38%

1M Leistung:

-20.31%

6M Leistung:

-38.55%

1J Leistung:

-46.50%

1-Tages-Spanne:

$1.4501

$1.57

1-Wochen-Bereich:

$1.4501

$1.73

52-Wochen-Spanne:

$1.31

$4.42

Lixte Biotechnology Holdings Inc Stock (LIXT) Company Profile

Firmenname

Lixte Biotechnology Holdings Inc

Sektor

Healthcare (1195)

Branche

Biotechnology (683)

Telefon

310 203 2902

Adresse

248 ROUTE 25A, EAST SETAUKET

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

LIXT's Discussions on Twitter

Vergleichen Sie LIXT mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
LIXT	1.55	3.35M	0	-4.69M	-3.81M	-3.70
VRTX	450.63	115.43B	10.63B	-479.80M	-1.35B	13.33
REGN	749.04	82.04B	13.85B	4.65B	3.32B	35.06
ARGX	589.59	35.30B	1.86B	-40.29M	-1.28B	-4.16
ALNY	247.57	32.04B	2.09B	-332.26M	16.06M	-4.14
BNTX	106.97	24.89B	3.30B	-501.07M	1.03B	11.54

Lixte Biotechnology Holdings Inc Aktie (LIXT) Neueste Nachrichten

Nov 15, 2024

LIXTW (Lixte Biotechnology Holdings) Accounts Payable & Acc - GuruFocus.com

Nov 15, 2024

Oct 29, 2024

LIXT stock touches 52-week low at $1.53 amid market challenges - Investing.com Australia

Oct 29, 2024

Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket - Benzinga

Oct 29, 2024

Oct 28, 2024

LIXT stock touches 52-week low at $1.53 amid market challenges By Investing.com - Investing.com South Africa

Oct 28, 2024

Oct 23, 2024

Lixte Biotechnology granted extension to meet Nasdaq listing rules By Investing.com - Investing.com Australia

Oct 23, 2024

Lixte Biotechnology granted extension to meet Nasdaq listing rules - Investing.com

Oct 23, 2024

Oct 09, 2024

Lixte Biotechnology Holdings Inc WT (LIXTW-Q) QuotePress Release - The Globe and Mail

Oct 09, 2024

Oct 01, 2024

LIfT BioSciences raises £10m in first close of Series A to advance first-in-class allogeneic innate cell therapy - GlobeNewswire

Sep 24, 2024

Sep 23, 2024

Should investors be concerned about LYT’s high price-to-sales ratio? - US Post News

Sep 23, 2024

Lilium (NASDAQ:LILM) Earns Overweight Rating from Cantor Fitzgerald - MarketBeat

Sep 23, 2024

Liquidia Co. (NASDAQ:LQDA) Shares Bought by Rhumbline Advisers - Defense World

Sep 23, 2024

Pacer Advisors Inc. Has $16.07 Million Stock Position in Liquidity Services, Inc. (NASDAQ:LQDT) - Defense World

Sep 23, 2024

Lipella Pharmaceuticals Inc’s Market Journey: Closing Weak at 0.41, Down -2.35 - The Dwinnex

Sep 23, 2024

Renaissance Technologies LLC Sells 2,000 Shares of LSI Industries Inc. (NASDAQ:LYTS) - Defense World

Sep 23, 2024

Sep 22, 2024

Texas Permanent School Fund Corp Trims Position in Liquidity Services, Inc. (NASDAQ:LQDT) - Defense World

Sep 22, 2024

Sep 21, 2024

First Eagle Investment Management LLC Increases Stake in LSI Industries Inc. (NASDAQ:LYTS) - Defense World

Sep 21, 2024

Huber Capital Management LLC Acquires 241,814 Shares of Lyft, Inc. (NASDAQ:LYFT) - Defense World

Sep 21, 2024

Acadian Asset Management LLC Cuts Position in LSI Industries Inc. (NASDAQ:LYTS) - Defense World

Sep 21, 2024

Quest Partners LLC Invests $28,000 in LSI Industries Inc. (NASDAQ:LYTS) - Defense World

Sep 21, 2024

Sep 19, 2024

Investors who lost money with shares of Liquidia Corporation - openPR

Sep 19, 2024

Sep 18, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia CorporationLQDA - Kilgore News Herald

Sep 18, 2024

Sep 11, 2024

Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing - Yahoo Finance

Sep 11, 2024

Sep 10, 2024

Biotech Steals The Show Following Pre-Clinical Data Announcement - MSN

Sep 10, 2024

Sep 05, 2024